Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun 6:9:1188.
doi: 10.3389/fimmu.2018.01188. eCollection 2018.

The Pathologic Role of Toll-Like Receptor 4 in Prostate Cancer

Tongwen Ou  1 , Michael Lilly  2 , Wei Jiang  3   4
Affiliations
Review

The Pathologic Role of Toll-Like Receptor 4 in Prostate Cancer

Tongwen Ou et al. Front Immunol. .

Abstract

Toll-like receptor (TLR) 4 is expressed on normal and malignant prostate epithelial cells. The TLR4 and its downstream signaling pathways mediate innate immune responses in the host against invading pathogens. However, multiple lines of evidence shows that TLR4 expression is increased in prostate tissues from prostate cancer patients, and altered TLR4 signals may promote cancer development, as well as antitumor effects. In this review, we have summarized key features of the TLR4 signaling pathway and its associated immune responses and focused on the pathologic role of TLR4 in prostate carcinogenesis and tumor progression.

Keywords: bacteria; carcinogens; inflammation; prostate cancer; toll-like receptor 4.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Toll-like receptor (TLR) 4 signaling pathway. TLR4 signaling pathway can be regulated by MyD88-dependent and MyD88-independent pathways. Upon the activation of MyD88, IL-1 receptor-associated kinase (IRAK) and tumor necrosis factor-receptor-associated factor 6 (TRAF6) are recruited to lead to degradation of IKKβ and disinhibition of NF-κB, which results in pro-inflammatory cytokine production (e.g., TNF-α and IL-6). The MyD88 pathway signals also activate MAKP and extracellular signal-regulated kinase (ERK) through TRAF6, which results in AP-1 activation. The MyD88-independent pathway is TRIF dependent. Upon the activation of TRIF-related adaptor molecule (TRAM)/TRIF, TRAFs are recruited, which leads to interferon regulatory factor 3 (IRF3) activation and type I IFN production.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lopatin WB, Martynik M, Hickey DP, Vivas C, Hakala TR. Retrograde transurethral balloon dilation of prostate: innovative management of abacterial chronic prostatitis and prostatodynia. Urology (1990) 36(6):508–10.10.1016/0090-4295(90)80188-S - DOI - PubMed
    1. Morgan MG, Nally C, Hickey D, Murphy DM. Urethral and prostatic colonization and infection in patients undergoing prostatectomy. J Hosp Infect (1988) 12(3):199–206.10.1016/0195-6701(88)90007-2 - DOI - PubMed
    1. Norlen LJ, Blaivas JG. Unsuspected proximal urethral obstruction in young and middle-aged men. J Urol (1986) 135(5):972–6.10.1016/S0022-5347(17)45942-8 - DOI - PubMed
    1. Drach GW. Sexuality and prostatitis: a hypothesis. J Am Vener Dis Assoc (1976) 3(2 Pt 1):87–8. - PubMed
    1. Kundu SD, Lee C, Billips BK, Habermacher GM, Zhang Q, Liu V, et al. The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate (2008) 68(2):223–9.10.1002/pros.20710 - DOI - PubMed

Publication types